Francisco Xavier Guerra-Castillo

Dr. Francisco Xavier Guerra-Castillo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CBCarolina Bekker-Mendez
Carolina Bekker-Mendez
EMEnrique Miranda-Peralta
Enrique Miranda-Peralta
Juan Carlos Núñez-EnríquezJuan Carlos Núñez-Enríquez
Juan Carlos Núñez-Enríquez
IOIrma Olarte-Carrillo
Irma Olarte-Carrillo
FGFrancisco Xavier Guerra-Castillo
Francisco Xavier Guerra-Castillo
JUAN MANUEL MEJIA-ARANGUREJUAN MANUEL MEJIA-ARANGURE
JUAN MANUEL MEJIA-ARANGURE
Mexico has one of the highest incidences of childhood leukemia worldwide and significantly higher mortality rates for this disease compared with other countries. One possible cause is the high prevalence of gene rearrangements associated with the etiology or with a poor prognosis of childhood acute lymphoblastic leukemia (ALL). The aims of this multicenter study were to determine the prevalence of the four most common gene rearrangements [ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, andMLLrearrangements] and to explore their relationship with mortality rates during the first year of treatment in ALL children from Mexico City. Patients were recruited from eight public hospitals during 2010–2012. A total of 282 bone marrow samples were obtained at each child’s diagnosis for screening by conventional and multiplex reverse transcription polymerase chain reaction to determine the gene rearrangements. Gene rearrangements were detected in 50 (17.7%) patients.ETV6-RUNX1was detected in 21 (7.4%) patients,TCF3-PBX1in 20 (7.1%) patients,BCR-ABL1in 5 (1.8%) patients, andMLLrearrangements in 4 (1.4%) patients. The earliest deaths occurred at months 1, 2, and 3 after diagnosis in patients withMLL, ETV6-RUNX1, andBCR-ABL1gene rearrangements, respectively. Gene rearrangements could be related to the aggressiveness of leukemia observed in Mexican children.

13 September 2022 in Archives of Medical Research
Verified
Journal Article
Closed access
SGSaúl González-Guzmán
Saúl González-Guzmán
PGPatricia González-Cano
Patricia González-Cano
EBEdward T. Bagu
Edward T. Bagu
SVSalvador Vázquez-Vega
Salvador Vázquez-Vega
MMMartha Martínez-Salazar
Martha Martínez-Salazar
VPVladimir Paredes-Cervantes
Vladimir Paredes-Cervantes

1 November 2016 in Archives of Medical Research
Verified
Journal Article
Closed access
SJSILVIA JIMENEZ-MORALES
SILVIA JIMENEZ-MORALES
MRMireya Ramírez-Florencio
Mireya Ramírez-Florencio
JUAN MANUEL MEJIA-ARANGUREJUAN MANUEL MEJIA-ARANGURE
JUAN MANUEL MEJIA-ARANGURE
Juan Carlos Núñez-EnríquezJuan Carlos Núñez-Enríquez
Juan Carlos Núñez-Enríquez
CBCarolina Bekker-Mendez
Carolina Bekker-Mendez
AHAlfredo Hidalgo-Miranda
Alfredo Hidalgo-Miranda

1 November 2016 in Archives of Medical Research
Verified
Journal Article
Closed access
CBCarolina Bekker-Mendez
Carolina Bekker-Mendez
Juan Carlos Núñez-EnríquezJuan Carlos Núñez-Enríquez
Juan Carlos Núñez-Enríquez
JEJosé Luis Torres Escalante
José Luis Torres Escalante
EAEnrique Alvarez-Olmos
Enrique Alvarez-Olmos
PGPablo Miguel González-Montalvoc
Pablo Miguel González-Montalvoc
JUAN MANUEL MEJIA-ARANGUREJUAN MANUEL MEJIA-ARANGURE
JUAN MANUEL MEJIA-ARANGURE

20 February 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
ACAndrea Santos Coy
Andrea Santos Coy
JAJulio Elias Alvarado-Yaah
Julio Elias Alvarado-Yaah
LULuis Antonio Uribe-Noguez
Luis Antonio Uribe-Noguez
FGFrancisco Xavier Guerra-Castillo
Francisco Xavier Guerra-Castillo
CSClara Esperanza Santacruz-Tinoco
Clara Esperanza Santacruz-Tinoco
LMLarissa Fernandes Matano
Larissa Fernandes Matano
SARS-CoV-2 has spread throughout the world since 2019, changing in its genome and leading to the appearance of new variants. This gave it different evolutionary advantages, such as greater infectivity and/or a greater ability to avoid the immune response, which could lead to an increased severity of COVID-19 cases. There is no consistent information about the viral load that occurs in infection with the different SARS-CoV-2 variants, hence, in this study we quantify the viral load of more than 16,800 samples taken from the Mexican population with confirmed diagnosis of COVID-19 and we analyze the relation between different demographic and disease variables. We detected that the viral load caused by different variants differs only in the first two days after the onset of symptoms, being higher when infections are caused by the delta variant and lower when caused by omicron. Furthermore, the viral load appears to be higher in outpatients compared to hospitalized patients or in cases of death. On the other hand, no differences were found in the viral load produced in vaccinated and unvaccinated patients, nor did it differ between genders.

6 February 2020 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
ETEmiliano Tesoro-Cruz
Emiliano Tesoro-Cruz
Norma Angélica OviedoNorma Angélica Oviedo
Norma Angélica Oviedo
LMLeticia Manuel-Apolinar
Leticia Manuel-Apolinar
SOSandra Orozco-Suárez
Sandra Orozco-Suárez
MMMiguel Perez de la Mora
Miguel Perez de la Mora
CBCarolina Bekker-Mendez
Carolina Bekker-Mendez